Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Desconocido
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy With Racotumomab Plus Best Support Treatment Versus Best Support Treatment in Patients With Advanced Non-small Cell Lung Camcer.
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01460472
Completado
Fase 3
ClinicalTrials.gov
A Placebo and Active Controlled Study to Assess the Long-term Safety of Once Daily QVA149 for 52 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients With Moderate to Severe Airflow Limitation
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01610037
Terminado
Fase 2
ClinicalTrials.gov
A Phase 1/2, Open-Label, Uncontrolled, Multiple Dose Escalation, Cohort Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Relapsed/Refractory Lymphoma, Myelofibrosis, Chronic Lymphocytic Leukemia, And Advanced Solid Tumors
INTERVENTIONAL
Inicio: 1 de may de 2015
ID: NCT02440685
Terminado
Fase 2
ClinicalTrials.gov
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of UK-500,001 Dry Powder For Inhalation (DPI) In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).
INTERVENTIONAL
Inicio: 1 de nov de 2005
ID: NCT00263874
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Multicenter, Phase 3 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers
INTERVENTIONAL
Inicio: 30 de sept de 2014
ID: NCT02264990
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Open-Label, Parallel-Group, Phase IIIb Study to Assess the Potential for Tezepelumab-treated Patients With Severe Asthma to Reduce Background Therapy While Sustaining Asthma Control and Clinical Remission
INTERVENTIONAL
Inicio: 30 de sept de 2024
ID: NCT06473779
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2a Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 16 de mar de 2023
ID: NCT05612035
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy
INTERVENTIONAL
Inicio: 17 de jul de 2009
ID: NCT00858364
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
INTERVENTIONAL
Inicio: 8 de may de 2018
ID: NCT03496623
Completado
Fase 3
ClinicalTrials.gov
MEA115588 A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
INTERVENTIONAL
Inicio: 8 de oct de 2012
ID: NCT01691521
Aún no recluta
ClinicalTrials.gov
Association Between Fatty Liver and Pancreatic Steatosis in Patients With Metabolic Syndrome
OBSERVATIONAL
Inicio: 1 de sept de 2025
ID: NCT06757348
Completado
Fase 3
ClinicalTrials.gov
A 52-week Treatment, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol (300 and 600 µg Once Daily) in Patients With Chronic Obstructive Pulmonary Disease, Using Formoterol (12 µg Twice Daily) as an Active Control
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00393458
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2 Open-Label Study in Infants With REspiratory Syncytial VIRus Lower RespirAtory Tract Infection, Followed by a DoubLe-blind, Placebocontrolled Part, to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Effect of RV521 (REVIRAL 1)
INTERVENTIONAL
Inicio: 13 de nov de 2019
ID: NCT04225897
Retirado
Fase 2
ClinicalTrials.gov
Safety and Efficacy of Inhaled XW001 (Interleukin 29 Analog for Nebulization) For Hospitalized COVID-19 Patients Requiring Oxygen Therapy: A Multiregional, Randomized, Double-blind, Placebo-controlled Study
INTERVENTIONAL
Inicio: 30 de oct de 2021
ID: NCT05083117
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5 µg [2 Actuations of 2.5 ug] and 10 ug [2 Actuations of 5 ug]) Delivered by the Respimat® Inhaler, and 48 Weeks of Twice Daily Foradil® (12 µg) Delivered by the Aerolizer® Inhaler, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de ene de 2009
ID: NCT00796653
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Multicenter Study of the Effects of Fluticasone Propionate/Salmeterol Combination Product 250/50mcg BID (ADVAIR DISKUS™) in Comparison to Salmeterol 50mcg BID (SEREVENT DISKUS™) on the Rate of Exacerbations of COPD Following Hospitalization
INTERVENTIONAL
Inicio: 30 de abr de 2010
ID: NCT01110200
Completado
ClinicalTrials.gov
Prone vs Supine Position in Potential Organ Donors: PRODONAR Multicenter Clinical Trial
INTERVENTIONAL
Inicio: 1 de jun de 2023
ID: NCT07251777
Completado
ClinicalTrials.gov
The Reliability of Noninvasive Effective Pulmonary Blood Flow to Detect Fluid Responsiveness During a Positive End-expirator Trial in Ventilated Patients
OBSERVATIONAL
Inicio: 5 de sept de 2018
ID: NCT03693365
Activo, no recluta
Fase 3
ClinicalTrials.gov
LIBRETTO-431: A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Selpercatinib to Platinum-Based and Pemetrexed Therapy With or Without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 17 de feb de 2020
ID: NCT04194944
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
INTERVENTIONAL
Inicio: 11 de may de 2023
ID: NCT05649722
Anterior
1
...
32
33
34
...
434
Siguiente
Filtros